Regulation (EU) No 576/2013 of the European Parliament and of the CouncilDangos y teitl llawn

ANNEX I Species of pet animals

PART A

Dogs (Canis lupus familiaris)

Cats (Felis silvestris catus)

Ferrets (Mustela putorius furo)

PART B

Invertebrates (except bees and bumble bees covered by Article 8 of Directive 92/65/EEC and molluscs and crustaceans referred to respectively in points (e)(ii) and (e)(iii) of Article 3(1) of Directive 2006/88/EC).

Ornamental aquatic animals as defined in point (k) of Article 3 of Directive 2006/88/EC and excluded from the scope of that Directive by point (a) of Article 2(1) thereof.

Amphibia

Reptiles

Birds: specimens of avian species other than those referred to in Article 2 of Directive 2009/158/EC.

Mammals: rodents and rabbits other than those intended for food production and defined under ‘lagomorphs’ in Annex I to Regulation (EC) No 853/2004.

ANNEX II Technical requirements for transponders

The transponders must:

(a)

comply with ISO Standard 11784 and apply HDX or FDX-B technology; and

(b)

be capable of being read by a reading device compatible with ISO Standard 11785.

ANNEX III Validity requirements for anti-rabies vaccinations

1. The anti-rabies vaccine must:

(a)

be a vaccine other than a live modified vaccine and fall within one of the following categories:

(i)

an inactivated vaccine of at least one antigenic unit per dose (recommendation from the World Health Organisation); or

(ii)

a recombinant vaccine expressing the immunising glycoprotein of the rabies virus in a live virus vector;

(b)

where it is administered in a Member State, it must have been granted a marketing authorisation in accordance with:

(i)

Article 5 of Directive 2001/82/EC; or

(ii)

Article 3 of Regulation (EC) No 726/2004;

(c)

where it is administered in a territory or a third country, have been granted an approval or a licence by the competent authority and meet at least the requirements laid down in the relevant part of the Chapter concerning rabies in the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the World Organisation for Animal Health.

2. An anti-rabies vaccination must fulfil the following conditions:

(a)

the vaccine was administered by an authorised veterinarian;

(b)

the pet animal was at least 12 weeks old at the date on which the vaccine was administered;

(c)

the date of administration of the vaccine is indicated by an authorised veterinarian or an official veterinarian in the appropriate section of the identification document;

(d)

the date of administration referred to in point (c) does not precede the date of application of the transponder or tattoo or the date of reading of the transponder or the tattoo indicated in the appropriate section of the identification document;

(e)

the period of validity of the vaccination starts from the establishment of protective immunity, which shall not be less than 21 days from the completion of the vaccination protocol required by the manufacturer for the primary vaccination, and continues until the end of the period of protective immunity, as prescribed in the technical specification of the marketing authorisation referred to in point 1(b) or the approval or licence referred to in point 1(c) for the anti-rabies vaccine in the Member State or territory or third country where the vaccine is administered.

The period of validity of the vaccination is indicated by an authorised veterinarian or an official veterinarian in the appropriate section of the identification document;

(f)

a revaccination must be considered a primary vaccination if it was not carried out within the period of validity referred to in point (e) of the previous vaccination.

ANNEX IV Validity requirements for the rabies antibody titration test

1. The collection of the sample of blood necessary to carry out the rabies antibody titration test must be carried out and documented by an authorised veterinarian in the appropriate section of the identification document;

2. The rabies antibody titration test:

(a)

must be carried out on a sample collected at least 30 days after the date of vaccination and:

(i)

not less than three months before the date of:

• the non-commercial movement from a territory or a third country other than those listed in the implementing acts adopted pursuant to Article 13(1) or (2), or

• the transit through such a territory or third country, where the conditions laid down in point (c) of Article 12 are not fulfilled, or

(ii)

before the pet animal left the Union for movement to or transit through a territory or a third country other than those listed pursuant to Article 13(1) or (2); the identification document in the format provided for in Article 21(1) must confirm that a rabies antibody titration test was carried out with a favourable result before the date of movement;

(b)

must measure a level of neutralising antibody to rabies virus in serum equal to or greater than 0,5 IU/ml and using a method prescribed in the relevant part of the Chapter concerning rabies in the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the World Organisation for Animal Health;

(c)

must be performed in a laboratory approved in accordance with Article 3 of Decision 2000/258/EC;

(d)

does not have to be renewed following a satisfactory result described in point (b), provided that the pet animal is revaccinated within the period of validity referred to in point 2(e) of Annex III of the previous vaccination.

ANNEX V

Correlation table referred to in Article 43(2)

Regulation (EC) No 998/2003	This Regulation
Article 1	Article 1
First paragraph of Article 2	Article 2(1)
Second paragraph of Article 2	Point (a) of Article 2(2)
Third paragraph of Article 2	Point (b) of Article 2(2)
Point (a) of Article 3	Points (a) and (b) of Article 3
Point (b) of Article 3	Point (f) of Article 3
Point (c) of Article 3	Article 2(1)
First subparagraph of Article 4(1)
	First subparagraph of Article 17(1)
Second subparagraph of Article 4(1)	Second subparagraph of Article 17(1)
Article 4(2)	—
Article 4(3)	—
Article 4(4)	—
Point (a) of Article 5(1)	Point (a) of Article 6
Point (b) of Article 5(1)	Point (d) of Article 6
Point (b)(i)Article 5(1)	Point (b) of Article 6
Point (b)(ii) of Article 5(1)	Point (c) of Article 6
Second subparagraph of Article 5(1)	Article 19
Article 5(2)	Article 7
Article 6	—
Article 7	Article 5(5), Articles 9, 14 and 28
Article 8(1)	Articles 10 and 12
Article 8(2)	Article 10(1)(e) and Article 27
Point (a) of Article 8(3)	Article 13(1)
Point (b) of Article 8(3)	Article 16
Point (c) of Article 8(3)	Article 11
Article 8(4)	Article 25(1) and (2)
Article 9	Article 14 and Article 30(1) and (2)
First subparagraph of Article 10	Article 13(2)
Second subparagraph of Article 10	Article 13(3)
First sentence of Article 11	Article 37(1)
Second sentence of Article 11	Point (a) of Article 34(4)
Introductory phrase and point (a) of the first subparagraph of Article 12	Article 10(2) and Article 34(1)
Introductory phrase and point (b) of the first subparagraph of Article 12	Article 5(4)
Second subparagraph of Article 12	Article 34(3) and Article 37(2)(d)
Article 13	Article 34(3) and Article 37(2)(d)
First paragraph of Article 14	Point (a) of Article 34(2)
Second paragraph of Article 14	Second subparagraph of Article 17(1)
Third paragraph of Article 14	Article 35(1) and (3)
Fourth paragraph of Article 14	Article 35(2)
Article 15	Points 1 and 2(c) of Annex IV
Article 16	—
First paragraph of Article 17	—
Second paragraph of Article 17	Article 21(1)
First paragraph of Article 18	—
Second paragraph of Article 18	Article 36
Article 19	Article 13(3) and Article 5(5)
Article 19a(1) and (2)	Article 38
Article 19a(3)	—
Article 19b(1)	Article 39(2)
Article 19b(2)	Article 39(4)
Article 19b(3)	Article 39(1)
Article 19c(1) and (3)	Article 39(3)
Article 19c(2)	—
Article 19d(1) and Article 19d(2)	Article 39(5)
Article 19d(3)	—
Articles 20 to 23	—
Article 24(1), (2) and (3)	Article 41(1), (2) and (3)
Article 24(4) and (5)	—
Article 25	Article 45
Annex I	Annex I
Annex Ia	Annex II
Annex Ib	Annex III
Part A and Section 1 of Part B of Annex II	—
Section 2 of Part B of Annex II	Article 13(1)
Part C of Annex II	Article 13(2)